Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
vTv Therapeutics (VTVT)
NASDAQ:VTVT
VTVT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.10 - $30.99
Previous CloseN/A
Volume611.00
Average Volume (3M)8.73K
Market Cap
$66.63M
Enterprise Value$35.56M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.70
Next Earnings
May 08, 2025EPS Estimate
-0.87Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.53
Shares Outstanding2,612,257
10 Day Avg. Volume11,016
30 Day Avg. Volume8,735
Standard Deviation0.24
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)66.63
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.53
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-2.62
Enterprise Value/Ebitda-1.60
Forecast
1Y Price Target
$35.00Price Target Upside73.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
vTv Therapeutics News
PremiumCompany Announcements
vTv Therapeutics Highlights Progress on Diabetes Treatment
PremiumCompany Announcements
vTv Therapeutics Faces License Agreement Termination
---
Ownership Overview
19.44% Insiders
8.77% Mutual Funds
11.64% Other Institutional Investors
58.44% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VTVT FAQ
What was vTv Therapeutics’s price range in the past 12 months?
vTv Therapeutics lowest stock price was $8.10 and its highest was $30.99 in the past 12 months.
What is vTv Therapeutics’s market cap?
vTv Therapeutics’s market cap is $66.63M.
When is vTv Therapeutics’s upcoming earnings report date?
vTv Therapeutics’s upcoming earnings report date is May 08, 2025 which is in 75 days.
How were vTv Therapeutics’s earnings last quarter?
Currently, no data Available
Is vTv Therapeutics overvalued?
According to Wall Street analysts vTv Therapeutics’s price is currently Undervalued.
Does vTv Therapeutics pay dividends?
vTv Therapeutics does not currently pay dividends.
What is vTv Therapeutics’s EPS estimate?
vTv Therapeutics’s EPS estimate is -0.87.
How many shares outstanding does vTv Therapeutics have?
vTv Therapeutics has 2,612,257 shares outstanding.
What happened to vTv Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of vTv Therapeutics?
Currently, no hedge funds are holding shares in VTVT
---
vTv Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$35.00 (73.27% Upside)
$35.00 (73.27% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
118.62%
12-Months-Change
Fundamentals
Return on Equity
-121.97%
Trailing 12-Months
Asset Growth
189.23%
Trailing 12-Months
Company Description
vTv Therapeutics
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
---
VTVT Stock 12 Month Forecast
Average Price Target
$35.00
▲(73.27% Upside)
Technical Analysis
Best Analysts Covering VTVT
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+1.70%
initiated a buy rating 3 months ago
Copying James Molloy's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +1.70% per trade.
---